FindTrial
Sign In

Expression of Notch family proteins in different pathological types patients with bladder cancer

Expression of Notch family proteins in different pathological types patients with bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019813
Enrollment
Unknown
Registered
2018-11-30
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tumor

Interventions

non-muscle invasive high grade group:Immunohistochemical staining for Notch family proteins
Normal control Group:Immunohistochemical staining for Notch family proteins
muscle invasive high grade group:Immunohistochemical staining for Notch family proteins
muscle invasive low grade group:Immunohistochemical staining for Notch family proteins
non-muscle invasive low grade group: Immunohistochemical staining for Notch family proteins

Sponsors

Shandong Provincial Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients whose pathologic diagnosis after the transurethral resection of bladder tumor is bladder urothelial carcinoma; 2. Adult patients who were treated for the first time; 3. All tumors visible to the naked eye were removed intraoperatively.

Exclusion criteria

Exclusion criteria: 1. Relapsed patients; 2. Patients with a history of malignant tumors other than bladder cancer.

Design outcomes

Primary

MeasureTime frame
Notch 1;Notch 2;Notch 3;Notch 4;Delta 1;Delta 3;Delta 4;Jagged 1;Jagged 2;—

Countries

China

Contacts

Public ContactYongliang Ni

Shandong Provincial Third Hospital

nyl_cabin@163.com+86 18613699256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026